Search

Carol M. Koslow

Examiner (ID: 12920, Phone: (571)272-1371 , Office: P/1734 )

Most Active Art Unit
1734
Art Unit(s)
1734, 1754, 1793, 1755, 1108
Total Applications
5011
Issued Applications
4022
Pending Applications
258
Abandoned Applications
784

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12862237 [patent_doc_number] => 20180179253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-28 [patent_title] => CELL PENETRATING PEPTIDES FOR INTRACELLULAR DELIVERY OF MOLECULES [patent_app_type] => utility [patent_app_number] => 15/802402 [patent_app_country] => US [patent_app_date] => 2017-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5753 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15802402 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/802402
Cell penetrating peptides for intracellular delivery of molecules Nov 1, 2017 Issued
Array ( [id] => 16176935 [patent_doc_number] => 20200223903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => Peptides Derived from Fibronectin with Improved Bioactivity and Reduced Susceptibility to Neutrophil Elastase Degradation [patent_app_type] => utility [patent_app_number] => 16/341686 [patent_app_country] => US [patent_app_date] => 2017-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16222 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341686 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/341686
Peptides derived from fibronectin with improved bioactivity and reduced susceptibility to neutrophil elastase degradation Oct 11, 2017 Issued
Array ( [id] => 13606909 [patent_doc_number] => 20180355003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-13 [patent_title] => COMPOSITIONS FOR DETECTION, INHIBITION AND IMAGING OF INDOLEAMINE 2, 3-DIOXYGENASE 1 (IDO1) AND METHODS OF MAKING AND USING SAME [patent_app_type] => utility [patent_app_number] => 15/721512 [patent_app_country] => US [patent_app_date] => 2017-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17733 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15721512 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/721512
Compositions for detection, inhibition and imaging of indoleamine 2, 3-dioxygenase 1 (IDO1) and methods of making and using same Sep 28, 2017 Issued
Array ( [id] => 14864851 [patent_doc_number] => 20190282667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-19 [patent_title] => NOVEL FORMULATIONS [patent_app_type] => utility [patent_app_number] => 16/337730 [patent_app_country] => US [patent_app_date] => 2017-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33918 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -54 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16337730 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/337730
NOVEL FORMULATIONS Sep 28, 2017 Pending
Array ( [id] => 14621923 [patent_doc_number] => 20190224329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-25 [patent_title] => Incremental Dose Finding in Controlled-Release PTH Compounds [patent_app_type] => utility [patent_app_number] => 16/337803 [patent_app_country] => US [patent_app_date] => 2017-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29955 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16337803 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/337803
Incremental dose finding in controlled-release PTH compounds Sep 27, 2017 Issued
Array ( [id] => 12580941 [patent_doc_number] => 20180085476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-29 [patent_title] => Activatable Membrane-Interacting Peptides and Methods of Use [patent_app_type] => utility [patent_app_number] => 15/700880 [patent_app_country] => US [patent_app_date] => 2017-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25033 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -40 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15700880 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/700880
Activatable membrane-interacting peptides and methods of use Sep 10, 2017 Issued
Array ( [id] => 14867981 [patent_doc_number] => 20190284232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-19 [patent_title] => PEPTIDES AND PEPTIDE CONJUGATES FOR TREATING MENTAL DISORDERS [patent_app_type] => utility [patent_app_number] => 16/329062 [patent_app_country] => US [patent_app_date] => 2017-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19533 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16329062 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/329062
PEPTIDES AND PEPTIDE CONJUGATES FOR TREATING MENTAL DISORDERS Sep 5, 2017 Abandoned
Array ( [id] => 14501191 [patent_doc_number] => 20190194250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-27 [patent_title] => PROCESSES FOR SEPARATING AGGREGATED PROTEINS FROM MONOMERIC PROTEINS IN A BIOLOGICAL SOLUTION [patent_app_type] => utility [patent_app_number] => 16/330304 [patent_app_country] => US [patent_app_date] => 2017-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25412 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16330304 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/330304
PROCESSES FOR SEPARATING AGGREGATED PROTEINS FROM MONOMERIC PROTEINS IN A BIOLOGICAL SOLUTION Aug 29, 2017 Pending
Array ( [id] => 12641016 [patent_doc_number] => 20180105503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-19 [patent_title] => NEPRILYSIN INHIBITORS [patent_app_type] => utility [patent_app_number] => 15/689168 [patent_app_country] => US [patent_app_date] => 2017-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26235 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15689168 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/689168
NEPRILYSIN INHIBITORS Aug 28, 2017 Abandoned
Array ( [id] => 14196647 [patent_doc_number] => 10265409 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-23 [patent_title] => Macromolecules [patent_app_type] => utility [patent_app_number] => 15/688780 [patent_app_country] => US [patent_app_date] => 2017-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22430 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15688780 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/688780
Macromolecules Aug 27, 2017 Issued
Array ( [id] => 13854075 [patent_doc_number] => 10188744 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-29 [patent_title] => Amphipathic peptide [patent_app_type] => utility [patent_app_number] => 15/688484 [patent_app_country] => US [patent_app_date] => 2017-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 121 [patent_no_of_words] => 20969 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15688484 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/688484
Amphipathic peptide Aug 27, 2017 Issued
Array ( [id] => 12588879 [patent_doc_number] => 20180088122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-29 [patent_title] => USE OF CD36 TO IDENTIFY CANCER SUBJECTS FOR TREATMENT [patent_app_type] => utility [patent_app_number] => 15/684639 [patent_app_country] => US [patent_app_date] => 2017-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11929 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15684639 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/684639
Use of CD36 to identify cancer subjects for treatment Aug 22, 2017 Issued
Array ( [id] => 16459401 [patent_doc_number] => 10842728 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-24 [patent_title] => Light-absorbing compositions and methods of use [patent_app_type] => utility [patent_app_number] => 15/682388 [patent_app_country] => US [patent_app_date] => 2017-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 28218 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15682388 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/682388
Light-absorbing compositions and methods of use Aug 20, 2017 Issued
Array ( [id] => 12785821 [patent_doc_number] => 20180153776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-07 [patent_title] => APPLICATION AND USES OF PRG4 AND THERAPEUTIC MODULATION THEREOF [patent_app_type] => utility [patent_app_number] => 15/676433 [patent_app_country] => US [patent_app_date] => 2017-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12584 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15676433 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/676433
Application and uses of PRG4 and therapeutic modulation thereof Aug 13, 2017 Issued
Array ( [id] => 14406781 [patent_doc_number] => 20190169234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => PEPTIDE INHIBITORS OF PHOSPHOGLYCERATE MUTASE AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 16/324424 [patent_app_country] => US [patent_app_date] => 2017-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23856 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16324424 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/324424
Peptide inhibitors of phosphoglycerate mutase and methods of use Aug 9, 2017 Issued
Array ( [id] => 17020986 [patent_doc_number] => 20210244857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-12 [patent_title] => PEPTIDE-COATED CALCIUM PHOSPHATE PARTICLES [patent_app_type] => utility [patent_app_number] => 16/319849 [patent_app_country] => US [patent_app_date] => 2017-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8209 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16319849 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/319849
PEPTIDE-COATED CALCIUM PHOSPHATE PARTICLES Jul 24, 2017 Pending
Array ( [id] => 16941080 [patent_doc_number] => 11053301 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-06 [patent_title] => Methods and compositions relating to covalently circularized nanodiscs [patent_app_type] => utility [patent_app_number] => 16/317924 [patent_app_country] => US [patent_app_date] => 2017-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 48 [patent_no_of_words] => 24640 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16317924 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/317924
Methods and compositions relating to covalently circularized nanodiscs Jul 16, 2017 Issued
Array ( [id] => 12000301 [patent_doc_number] => 20170304456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'FAST DISSOLVING PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 15/644933 [patent_app_country] => US [patent_app_date] => 2017-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8974 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15644933 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/644933
FAST DISSOLVING PHARMACEUTICAL COMPOSITION Jul 9, 2017 Abandoned
Array ( [id] => 11977567 [patent_doc_number] => 20170281722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'Treatment of Constipation-Predominant Irritable Bowel Syndrome' [patent_app_type] => utility [patent_app_number] => 15/624862 [patent_app_country] => US [patent_app_date] => 2017-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10571 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 45 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15624862 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/624862
Treatment of Constipation-Predominant Irritable Bowel Syndrome Jun 15, 2017 Abandoned
Array ( [id] => 11962111 [patent_doc_number] => 20170266263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-21 [patent_title] => 'METHODS FOR INCREASING INTRACELLULAR ACTIVITY OF HSP70' [patent_app_type] => utility [patent_app_number] => 15/600407 [patent_app_country] => US [patent_app_date] => 2017-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 38226 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15600407 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/600407
Methods for increasing intracellular activity of Hsp70 May 18, 2017 Issued
Menu